Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 5Completed 5Unknown 2Active not recruiting 2Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leiomyoma 1

Interventions

Cyclophosphamide 390Carboplatin 343Gemcitabine 331pembrolizumab 330Cisplatin 327Paclitaxel 295Radiotherapy 292Docetaxel 286Bevacizumab 249Rituximab 233Capecitabine 222Nivolumab 220Dexamethasone 205Fluorouracil 189fludarabine 178Oxaliplatin 177Pemetrexed 153Doxorubicin 152Irinotecan 147Etoposide 144Leucovorin 143Cytarabine 134fludarabine phosphate 129Bortezomib 129Cetuximab 127Lenalidomide 125Filgrastim 120Erlotinib Hydrochloride 119Temozolomide 111Ipilimumab 111

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Interventional × epigallocatechin gallate × Clear all
NCT01311869 2013-10-24

Green Tea Extract: a Non-Surgical Alternative for Treatment of Uterine Fibroids

Meharry Medical College

Phase 2 Terminated
43 enrolled

Leiomyoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡